Top Section/Ad
Top Section/Ad
Most recent
DocMorris announces Sfr200m rights issue expected in May
Stock drops 17% in highly volatile market
Deal follows steep share price fall
More articles/Ad
More articles/Ad
More articles
-
US drug maker's stake in Haleon set to fall to 24% -
Risk appetite is back and more deals coming, though one bad IPO would damage confidence in the recovery
-
More companies are getting ratings to woo bond investors
-
Europe's biggest IPO of the year so far gains traction with investors
-
After the listings in February delivered, Galderma adds fuel to the European IPO recovery
-
Long delayed listing of Nestlé's former skincare division is finally underway
